Anaemia and agranulocytosis associated with ticlopidine therapy.
Although ticlopidine has proven anti-aggregant properties, complications due to side-effects, particularly to the haemopoietic system, have been noted since it was recently launched on the market. We here report a case of bicytopenia (anaemia and granulocytopenia) associated with ticlopidine treatment.
D000380:Agranulocytosis / Q000139:chemically induced*; D000740:Anemia / Q000139:chemically induced*; D001797:Blood Protein Electrophoresis; D001856:Bone Marrow Examination; D002478:Cells, Cultured; D005260:Female; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects; D008875:Middle Aged; D013876:Thiophenes / Q000009:adverse effects*; D013988:Ticlopidine
D013876:Thiophenes; D013988:Ticlopidine